JEFFREY BACHA Insider Trading $KTRA Kintara Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEFFREY BACHA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEFFREY BACHA. JEFFREY BACHA is CEO in DelMar Pharmaceuticals, Inc. ($DMPI) and CEO, Director in DelMar Pharmaceuticals, Inc. ($DMPI) and Chief Executive Officer in DelMar Pharmaceuticals, Inc. ($DMPI) and Director in DelMar Pharmaceuticals, Inc. ($DMPI) and President, CEO in DelMar Pharmaceuticals, Inc. ($DMPI).
JEFFREY BACHA in Kintara Therapeutics, Inc.
Trading Symbol: KTRAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEFFREY BACHA: Chief Executive Officer, CEO, Director, President, CEO
Holdings: 64,049 shares
Latest Transaction: Apr 03 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JEFFREY BACHA in Kintara Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Buy | J | 3.20 | 176 | 563 | 64,049 | 63.9 K to 64 K (+0.28 %) |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Option Exercise | A | 4.95 | 93,600 | 463,320 | 93,600 | |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Option Exercise | D | 4.95 | 93,600 | 463,320 | 0 | |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Option Exercise | A | 4.20 | 87,500 | 367,500 | 87,500 | |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Option Exercise | D | 4.20 | 87,500 | 367,500 | 0 | |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Option Exercise | A | 2.00 | 37,500 | 75,000 | 37,500 | |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Option Exercise | D | 2.00 | 37,500 | 75,000 | 0 | |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Director | Buy | J | 3.20 | 176 | 563 | 63,873 | 63.7 K to 63.9 K (+0.28 %) |
Oct 10 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | P | 0.88 | 2,450 | 2,156 | 63,697 | 61.2 K to 63.7 K (+4.00 %) |
Oct 10 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | P | 0.87 | 7,550 | 6,569 | 61,247 | 53.7 K to 61.2 K (+14.06 %) |
Oct 02 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | J | 3.20 | 176 | 563 | 53,697 | 53.5 K to 53.7 K (+0.33 %) |
Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | J | 3.20 | 176 | 563 | 53,521 | 53.3 K to 53.5 K (+0.33 %) |
Jun 28 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | P | 3.60 | 6,700 | 24,120 | 53,345 | 46.6 K to 53.3 K (+14.36 %) |
Jun 06 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | P | 2.12 | 5,000 | 10,600 | 46,645 | 41.6 K to 46.6 K (+12.01 %) |
May 08 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Chief Executive Off ... | Buy | P | 2.20 | 2,500 | 5,500 | 41,645 | 39.1 K to 41.6 K (+6.39 %) |
Apr 04 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | Chief Executive Off ... | Buy | J | 3.20 | 176 | 563 | 39,145 | 39 K to 39.1 K (+0.45 %) |
Feb 22 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Option Exercise | A | 4.95 | 93,600 | 463,320 | 93,600 | |
Feb 02 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | P | 5.00 | 4,000 | 20,000 | 38,969 | 35 K to 39 K (+11.44 %) |
Jan 03 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | J | 3.20 | 176 | 563 | 34,969 | 34.8 K to 35 K (+0.51 %) |
Oct 05 2016 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | J | 3.20 | 176 | 563 | 34,793 | 34.6 K to 34.8 K (+0.51 %) |
Jul 19 2016 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | J | 3.20 | 120 | 384 | 34,617 | 34.5 K to 34.6 K (+0.35 %) |
May 03 2016 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO, Director | Option Exercise | P | 0.00 | 3,125 | 0 | 3,125 | |
Nov 30 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO, Director | Buy | P | 1.47 | 7,500 | 11,025 | 137,985 | 130.5 K to 138 K (+5.75 %) |
Oct 09 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | President, CEO | Buy | P | 0.78 | 200 | 156 | 130,485 | 130.3 K to 130.5 K (+0.15 %) |
Oct 09 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | President, CEO | Buy | P | 0.80 | 2,800 | 2,240 | 130,285 | 127.5 K to 130.3 K (+2.20 %) |
Sep 22 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | President, CEO | Buy | P | 0.83 | 4,000 | 3,320 | 127,485 | 123.5 K to 127.5 K (+3.24 %) |
Jul 28 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | President, CEO | Option Exercise | P | 0.75 | 10,000 | 7,500 | 60,000 | |
Jul 28 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | President, CEO | Buy | P | 0.60 | 10,000 | 6,000 | 123,485 | 113.5 K to 123.5 K (+8.81 %) |
Jul 16 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | President, CEO | Option Exercise | P | 0.75 | 50,000 | 37,500 | 50,000 | |
Jul 16 2015 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | President, CEO | Buy | P | 0.60 | 50,000 | 30,000 | 113,485 | 63.5 K to 113.5 K (+78.76 %) |
Page: 1